Partial
Partially Aligned
Patient Risk:
Low
Summary
Multiple claims are general regulatory/pharmacology statements not supported or assessable using the provided STROMECTOL (ivermectin tablets) label excerpts; one claim (pregnancy use) would be contradicted if the label is interpreted as 'should not be used during pregnancy,' but no such pregnancy claim was provided.
Category Scores
Accurate Statements
Ivermectin is an anthelmintic.
Not stated in the provided STROMECTOL label excerpts.
Ivermectin is used to treat parasitic infections.
Label indicates treatment of Strongyloidiasis (Strongyloides stercoralis) and Onchocerciasis (Onchocerca volvulus).
Ivermectin belongs to the drug class avermectins.
Not stated in the provided STROMECTOL label excerpts.
Other drugs in the avermectins class include abamectin and doramectin.
Not stated in the provided STROMECTOL label excerpts.
Unsupported Statements
Ivermectin is not currently available as a generic medication.
Not addressed in the provided STROMECTOL label excerpts.
The original patent for ivermectin expired in 1996.
Not addressed in the provided STROMECTOL label excerpts.
Brand-name formulations like Stromectol remain available.
The existence of STROMECTOL in the provided labeling does not support a claim about generic availability/regulatory status.
New patents can be issued for specific uses or formulations of existing drugs.
Not addressed in the provided STROMECTOL label excerpts.
Despite the expiration of the original patent, a generic version of ivermectin has not been approved by regulatory bodies.
Not addressed in the provided STROMECTOL label excerpts.
Ivermectin is an anthelmintic.
The provided STROMECTOL label excerpts do not use or define this drug-class/characterization term.
Ivermectin belongs to the drug class avermectins.
The provided STROMECTOL label excerpts do not state this classification.
Other drugs in the avermectins class include abamectin and doramectin.
The provided STROMECTOL label excerpts do not mention these drugs as class members.
Contradictions
Important Omissions
If the intent was to evaluate a claim about pregnancy safety (e.g., use in pregnancy), the provided STROMECTOL label excerpt explicitly states ivermectin should not be used during pregnancy because safety has not been established. No pregnancy-related claim was included to evaluate.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The unsupported claims largely concern patent/generic availability or broad drug-class statements not directly tied to dosing, contraindications, warnings, interactions, or specific patient safety requirements in the provided label excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Most claims are not supported by the provided STROMECTOL labeling excerpts (e.g., patent/generic availability and avermectin class membership). Only the general indication for parasitic infections aligns with label indications (strongyloidiasis and onchocerciasis).
Suggested Improvement
Evaluate only claims that map to specific label sections (e.g., indications, dosing, contraindications, warnings/precautions, drug interactions, and specified populations). Paste the exact claim text intended for evaluation and ensure the correct product label (STROMECTOL tablets vs SOOLANTRA cream) is used.